Please login to the form below

Not currently logged in
Email:
Password:

Watson reports positive oxybutynin phase III results for OAB

Watson Pharmaceuticals reports positive results from its late stage trial of oxybutynin topical gel in patients with overactive bladder

US-based Watson Pharmaceuticals has reported positive results from its late stage trial of oxybutynin topical gel (OTG) in patients with overactive bladder (OAB).

The company said that the study met its primary endpoint and secondary endpoints.
The phase III study is a multi-centre, double blind, placebo-controlled trial designed to evaluate the efficacy and safety of OTG in 789 patients with OAB.

The primary objective of the study was to demonstrate that daily treatment of a one-gram dose of OTG for 12 weeks was superior to placebo for the relief of OAB symptoms.

In addition, 216 patients participated in a 14-week, open label, safety-extension study for a total of 26 weeks. During the double-blind portion of the trial, highly statistically significant improvements relative to placebo were seen on all of these endpoints, according to Watson.

The study data showed that OTG was well tolerated in the study and no serious adverse events related to the treatment were reported.

Watson plans to submit NDA for OTG with the FDA in Q2 2008, adding that the product would be the first gel formulation for the treatment of OAB in 2009.

Shares in Watson were up USD 0.12 to rest at USD 26.20 in trading on 7 January 2008.

8th January 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...
Deal Watch January 2018
...
Emotional Intelligence and Blended Learning in Healthcare
EI and emotional selling are rising up the agenda when it comes to healthcare training. This article outlines how blended learning approaches can help put them into action....

Infographics